Radioligand Therapy with [ 177 Lu]Lu-DOTA-TATE or [ 177 Lu]Lu-DOTA-TATE and [ 90 Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade.
Saved in:
| Title: | Radioligand Therapy with [ 177 Lu]Lu-DOTA-TATE or [ 177 Lu]Lu-DOTA-TATE and [ 90 Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade. |
|---|---|
| Authors: | Durma, Adam Daniel1 (AUTHOR) adurma@wim.mil.pl, Saracyn, Marek1 (AUTHOR), Kołodziej, Maciej1 (AUTHOR), Jóźwik-Plebanek, Katarzyna1 (AUTHOR), Dmochowska, Beata1 (AUTHOR), Mróz, Adrianna1 (AUTHOR), Żmudzki, Wawrzyniec1 (AUTHOR), Kamiński, Grzegorz1 (AUTHOR) |
| Source: | Pharmaceuticals (14248247). Sep2023, Vol. 16 Issue 9, p1205. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
